Cancidas

Active Ingredient(s): Caspofungin
FDA Approved: * January 26, 2001
Pharm Company: * MERCK RES
Category: Antifungal

Caspofungin (INN)[1][3] (brand name Cancidas) is a lipopeptide antifungal drug from Merck & Co., Inc. discovered by James Balkovec, Regina Black and Frances A. Bouffard.[4] It is a member of a new class of antifungals termed the echinocandins. It works by inhibiting the enzyme (1→3)-β-D-glucan synthase and thereby disturbing the integrity of the fungal cell wall. Caspofungin was the first inhibitor of fungal (1→3)-β-D-... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Cancidas 5 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 0006-3822

Labeler:

Merck Sharp & Dohme Corp.

Cancidas 7 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 0006-3823

Labeler:

Merck Sharp & Dohme Corp.